[go: up one dir, main page]

TR201904270T4 - Tanımlı koşullar altında insan pluripotent kök hücrelerinin hematoendotelyal farklılaşması için yöntemler ve materyaller. - Google Patents

Tanımlı koşullar altında insan pluripotent kök hücrelerinin hematoendotelyal farklılaşması için yöntemler ve materyaller. Download PDF

Info

Publication number
TR201904270T4
TR201904270T4 TR2019/04270T TR201904270T TR201904270T4 TR 201904270 T4 TR201904270 T4 TR 201904270T4 TR 2019/04270 T TR2019/04270 T TR 2019/04270T TR 201904270 T TR201904270 T TR 201904270T TR 201904270 T4 TR201904270 T4 TR 201904270T4
Authority
TR
Turkey
Prior art keywords
stem cells
pluripotent stem
materials
methods
human pluripotent
Prior art date
Application number
TR2019/04270T
Other languages
English (en)
Inventor
Slukvin Igor
Ichiro Uenishi Gene
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of TR201904270T4 publication Critical patent/TR201904270T4/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0056—Xeno-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0695—Stem cells; Progenitor cells; Precursor cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/165—Vascular endothelial growth factor [VEGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1394—Bone marrow stromal cells; whole marrow
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Buluş, insan pluripotent kök hücrelerinin hematoendotelyal farklılaşması için uygun bir ksenojen içermeyen, albümin içermeyen bir hücre kültür ortamı sağlar.
TR2019/04270T 2013-03-13 2014-03-12 Tanımlı koşullar altında insan pluripotent kök hücrelerinin hematoendotelyal farklılaşması için yöntemler ve materyaller. TR201904270T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361779564P 2013-03-13 2013-03-13

Publications (1)

Publication Number Publication Date
TR201904270T4 true TR201904270T4 (tr) 2019-05-21

Family

ID=50678273

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/04270T TR201904270T4 (tr) 2013-03-13 2014-03-12 Tanımlı koşullar altında insan pluripotent kök hücrelerinin hematoendotelyal farklılaşması için yöntemler ve materyaller.

Country Status (18)

Country Link
US (3) US9938499B2 (tr)
EP (1) EP2970912B1 (tr)
JP (1) JP6677631B2 (tr)
KR (1) KR102151210B1 (tr)
CN (1) CN105209609B (tr)
AU (1) AU2014248651B2 (tr)
BR (1) BR112015022770B1 (tr)
CA (2) CA2905786C (tr)
DK (1) DK2970912T3 (tr)
ES (1) ES2720196T3 (tr)
HU (1) HUE043785T2 (tr)
IL (1) IL241286B (tr)
MX (1) MX366900B (tr)
PL (1) PL2970912T3 (tr)
PT (1) PT2970912T (tr)
SG (1) SG11201507275TA (tr)
TR (1) TR201904270T4 (tr)
WO (1) WO2014165131A1 (tr)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102651433B1 (ko) 2006-04-14 2024-03-25 아스텔라스 인스티튜트 포 리제너러티브 메디슨 혈관 콜로니 형성 세포
US9719068B2 (en) 2010-05-06 2017-08-01 Children's Hospital Medical Center Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
US9868939B2 (en) 2013-06-12 2018-01-16 Wisconsin Alumni Research Foundation Generating vasculogenic cell populations
CN106661548B (zh) 2014-05-28 2020-12-11 儿童医院医疗中心 用于经由定向分化将前体细胞转化为胃组织的方法和系统
AU2015331848B2 (en) 2014-10-17 2022-03-03 Children's Hospital Medical Center, D/B/A Cincinnati Children's Hospital Medical Center In vivo model of human small intestine using pluripotent stem cells and methods of making and using same
US11220672B2 (en) * 2014-12-31 2022-01-11 Wisconsin Alumni Research Foundation Human pluripotent stem cell-based system for generating endothelial cells
JP6800859B2 (ja) * 2015-01-26 2020-12-16 フェイト セラピューティクス，インコーポレイテッド 造血細胞分化を誘導するための方法および組成物
JP6691921B2 (ja) * 2015-02-20 2020-05-13 ウィスコンシン アラムニ リサーチ ファンデーション 動脈内皮細胞集団の生成
WO2016141084A1 (en) * 2015-03-03 2016-09-09 The Board Of Trustees Of The Leland Stanford Junior University Producing mesodermal cell types and methods of using the same
CN104660703B (zh) * 2015-03-05 2017-12-15 国家电网公司 多网络融合用电信息采集系统及最优通信网络的选择方法
US10836997B2 (en) * 2015-03-09 2020-11-17 Keio University Method for differentiating pluripotent stem cells into desired cell type
EP3313434B1 (en) * 2015-06-29 2025-04-02 Northeastern University Dendritic cell generator
JP6646311B2 (ja) * 2015-07-17 2020-02-14 国立大学法人京都大学 多能性幹細胞から中胚葉前駆細胞および血液血管前駆細胞への分化誘導法
JP7061961B2 (ja) * 2015-10-20 2022-05-02 フジフィルム セルラー ダイナミクス，インコーポレイテッド 多能性幹細胞の免疫細胞への分化を誘導する方法
US10858628B2 (en) 2015-11-04 2020-12-08 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
ES2953925T3 (es) * 2015-11-04 2023-11-17 Fate Therapeutics Inc Ingeniería genómica de células pluripotentes
CN108884441B (zh) * 2016-03-16 2022-05-06 洋蓟治疗有限公司 集落形成培养基及其用途
KR102428606B1 (ko) * 2016-04-15 2022-08-02 앤지오크린 바이오사이언스 인코포레이티드 향상된 유전자 전달 방법
US11066650B2 (en) 2016-05-05 2021-07-20 Children's Hospital Medical Center Methods for the in vitro manufacture of gastric fundus tissue and compositions related to same
WO2017200486A1 (en) * 2016-05-17 2017-11-23 Agency For Science, Technology And Research Human stem cell derived endothelial cells, endothelial- hepatocyte co-culture system and uses thereof
WO2018037091A1 (en) * 2016-08-24 2018-03-01 Hi-Stem Ggmbh Methods for the identification and isolation of hematopoietic stem and progenitor cells
CA3035660A1 (en) 2016-09-06 2018-03-15 The Children's Medical Center Corporation Immune cells derived from induced pluripotent stem cell
EP3523423B1 (en) * 2016-10-05 2024-07-31 FUJIFILM Cellular Dynamics, Inc. Methods for directed differentiation of pluripotent stem cells to hla homozygous immune cells
AU2017340634B2 (en) 2016-10-05 2022-06-02 FUJIFILM Cellular Dynamics, Inc. Generating mature lineages from induced pluripotent stem cells with MECP2 disruption
CN110062764B (zh) 2016-12-05 2024-07-02 儿童医院医学中心 结肠类器官及其制备和使用方法
CA3056709A1 (en) * 2017-03-21 2018-09-27 Etablissement Francais Du Sang Methods of improving hematopoietic grafts
CN106867961A (zh) * 2017-03-27 2017-06-20 广州润虹医药科技有限公司 一种诱导多能干细胞形成中胚层细胞的诱导培养基及诱导方法
CN110678191A (zh) * 2017-04-07 2020-01-10 洋蓟治疗有限公司 治疗嵌合抗原受体(car)t细胞疗法的副作用的方法
JP7248586B2 (ja) 2017-04-14 2023-03-29 チルドレンズ ホスピタル メディカル センター 複数ドナー幹細胞組成物およびそれを作製する方法
JP7181219B2 (ja) 2017-04-18 2022-11-30 フジフィルム セルラー ダイナミクス，インコーポレイテッド 抗原特異的免疫エフェクター細胞
WO2018227244A1 (en) * 2017-06-16 2018-12-20 Cynata Therapeutics Limited Method for treating a side effect of immunotherapy
WO2018229251A1 (en) * 2017-06-16 2018-12-20 Imba - Institut Für Molekulare Biotechnologie Gmbh Blood vessel organoid, methods of producing and using said organoids
WO2019051281A1 (en) * 2017-09-07 2019-03-14 StemoniX Inc. EFFECTIVE DIFFERENTIATION OF HUMAN STEM CELLS IN DEFINITIVE ENDODERM
JP2020533373A (ja) 2017-09-15 2020-11-19 サイナータ セラピューティクス リミテッド アレルギー性気道疾患（ａａｄ）／喘息の処置方法
JP2020536529A (ja) 2017-10-10 2020-12-17 チルドレンズ ホスピタル メディカル センター 食道組織および／または臓器組成物およびそれを作製する方法
WO2019084612A1 (en) 2017-10-31 2019-05-09 Murdoch Childrens Research Institute Composition and method
US12037607B2 (en) 2017-11-08 2024-07-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of preparing hematopoietic progenitor cells in vitro
CA3084575A1 (en) 2017-11-22 2019-05-31 Mesoblast International Sarl Cellular compositions and methods of treatment i
US11365390B2 (en) 2017-12-19 2022-06-21 Xcell Biosciences, Inc. Methods of modulating cell phenotype by way of regulating the gaseous environment
US12060576B2 (en) 2018-01-05 2024-08-13 Stellular Bio, Inc. Compositions and methods for producing megakaryocytes
JP2021535747A (ja) * 2018-09-07 2021-12-23 ウィスコンシン アラムニ リサーチ ファンデーション ヒト多能性幹細胞からの造血前駆細胞の生成
CN109334379B (zh) * 2018-09-19 2021-11-23 江苏大学 重型车用液电式惯容器非线性惯性力辨识方法
US10647954B1 (en) 2018-11-15 2020-05-12 Flaskworks, Llc Dendritic cell generating apparatus and method
WO2020154412A1 (en) * 2019-01-22 2020-07-30 Washington University Compositions and methods for generating hematopoietic stem cells (hscs)
CN109652369B (zh) * 2019-02-28 2020-01-03 西湖生物医药科技(杭州)有限公司 利用外周血体外制备成熟红细胞的方法及制剂
WO2021024207A1 (en) 2019-08-05 2021-02-11 Mesoblast International Sarl Cellular compositions comprising viral vectors and methods of treatment
US11566217B2 (en) 2019-08-13 2023-01-31 Flaskworks, Llc Duty cycle for cell culture systems
GB201911957D0 (en) * 2019-08-20 2019-10-02 Adaptimmune Ltd Methods of producing haemogenic progenitor cells from pluripotent stem cells
GB201911953D0 (en) * 2019-08-20 2019-10-02 Adaptimmune Ltd T cell production fram RAG inacivated iPSCs
BR112022003083A2 (pt) * 2019-08-20 2022-08-02 Adaptimmune Ltd Meio de cultura para indução hematopoiética
AU2020337929A1 (en) * 2019-08-28 2022-03-24 Astellas Institute For Regenerative Medicine Methods of treating vascular diseases
CN114901799A (zh) 2019-10-21 2022-08-12 弗拉斯沃克斯有限责任公司 用于细胞培养的系统和方法
WO2021085462A1 (ja) * 2019-10-29 2021-05-06 国立大学法人京都大学 多能性幹細胞から造血性内皮細胞および／または造血前駆細胞を製造する方法
US20230030773A1 (en) * 2019-12-16 2023-02-02 The Board Of Trustees Of The Leland Stanford Junior University Use of polyvinyl alcohol for cell culture of immune cells
JP7072756B2 (ja) * 2019-12-27 2022-05-23 国立大学法人京都大学 多能性幹細胞から中胚葉前駆細胞および血液血管前駆細胞への分化誘導法
CN113493767B (zh) * 2020-04-01 2024-04-26 北京大学 利用人多潜能干细胞体外制备嗜酸性粒细胞
EP4192940A1 (en) 2020-08-10 2023-06-14 Mesoblast International Sárl Cellular compositions and methods of treatment
JP2023540212A (ja) * 2020-08-25 2023-09-22 ユニバーシティー ヘルス ネットワーク ヒト卵黄嚢様造血細胞を生成するための組成物および方法
US11459372B2 (en) 2020-11-30 2022-10-04 Crispr Therapeutics Ag Gene-edited natural killer cells
US11473060B2 (en) 2020-12-30 2022-10-18 Crispr Therapeutics Ag Compositions and methods for differentiating stem cells into NK cells
CN112680410B (zh) * 2021-01-19 2022-08-02 上海爱萨尔生物科技有限公司 诱导多能干细胞分化培养心脏成纤维细胞的方法及其培养液
EP4293107A1 (en) * 2021-02-05 2023-12-20 Sungkwang Medical Foundation Method for differentiating pluripotent stem cell-derived hemogenic endothelial cells into lymphoid lineage cells
KR102766602B1 (ko) * 2021-02-05 2025-02-13 의료법인 성광의료재단 다능성 줄기세포 유래 조혈 내피세포를 이용한 유전자 편집된 세포의 제조방법
GB202102297D0 (en) * 2021-02-18 2021-04-07 Adaptimmune Ltd Methods of Producing Haemogenic Endothelial Cells from Pluripotent Stem Cells
CN113046318B (zh) * 2021-04-13 2023-04-18 中国科学院深圳先进技术研究院 一种诱导多能干细胞向造血前体细胞分化的培养基以及方法
WO2023019213A1 (en) * 2021-08-13 2023-02-16 Simcere Innovation, Inc. Three-dimensional culturing of pluripotent stem cells to produce hematopoietic stem cells
IL316055A (en) 2022-04-15 2024-11-01 Aspen Neuroscience Inc Methods of classifying the differentiation state of cells and related compositions of differentiated cells
WO2024173696A2 (en) * 2023-02-16 2024-08-22 Syntax Bio, Inc. Systems for cell programming towards hematopoietic lineage and methods thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2432846B (en) 2004-09-08 2009-12-30 Wisconsin Alumni Res Found Medium and culture of embryonic stem cells
US8034613B2 (en) 2005-06-01 2011-10-11 Wisconsin Alumni Research Foundation Multipotent lymphohematopoietic progenitor cells
KR20080015033A (ko) 2005-06-01 2008-02-15 위스콘신 얼럼나이 리서어치 화운데이션 배아 줄기 세포로부터 가지 세포를 형성하는 방법
GB2449042B (en) 2006-02-09 2010-07-07 Wisconsin Alumni Res Found Erythroid cells producing adult-type b-hemoglobin generated from human embryonic stem cells
SG193652A1 (en) 2007-03-23 2013-10-30 Wisconsin Alumni Res Found Somatic cell reprogramming
US7615374B2 (en) 2007-09-25 2009-11-10 Wisconsin Alumni Research Foundation Generation of clonal mesenchymal progenitors and mesenchymal stem cell lines under serum-free conditions
US20110236971A2 (en) * 2007-09-25 2011-09-29 Maksym Vodyanyk Generation of Clonal Mesenchymal Progenitors and Mesenchymal Stem Cell Lines Under Serum-Free Conditions
US8372643B2 (en) 2007-12-06 2013-02-12 Agency For Science, Technology And Research Method for extracellular matrix mediated differentiation and proliferation of stem cells
CN104328087A (zh) * 2008-05-06 2015-02-04 先进细胞技术公司 用于制备衍生自多能干细胞的去核类红细胞的方法
JP5816100B2 (ja) 2009-02-27 2015-11-18 セルラー ダイナミクス インターナショナル， インコーポレイテッド 多能性細胞の分化
WO2010143529A1 (ja) * 2009-06-09 2010-12-16 国立大学法人名古屋大学 多能性幹細胞を胸腺上皮へ分化誘導する方法
EP2563908B1 (en) * 2010-04-25 2019-01-09 Icahn School of Medicine at Mount Sinai Generation of anterior foregut endoderm from pluripotent cells
US9279107B2 (en) 2010-08-05 2016-03-08 Wisconsin Alumni Research Foundation Simplified basic media for human pluripotent cell culture

Also Published As

Publication number Publication date
SG11201507275TA (en) 2015-10-29
CN105209609B (zh) 2020-08-21
ES2720196T3 (es) 2019-07-18
AU2014248651A1 (en) 2015-10-01
MX366900B (es) 2019-07-30
IL241286B (en) 2020-03-31
MX2015012202A (es) 2015-11-30
IL241286A0 (en) 2015-11-30
PT2970912T (pt) 2019-05-31
BR112015022770B1 (pt) 2022-11-16
EP2970912B1 (en) 2019-03-06
WO2014165131A1 (en) 2014-10-09
KR102151210B1 (ko) 2020-09-02
CA2905786A1 (en) 2014-10-09
CA3141731A1 (en) 2014-10-09
JP6677631B2 (ja) 2020-04-08
AU2014248651B2 (en) 2019-01-17
EP2970912A1 (en) 2016-01-20
CN105209609A (zh) 2015-12-30
BR112015022770A2 (pt) 2017-07-18
PL2970912T3 (pl) 2019-08-30
JP2016512031A (ja) 2016-04-25
BR112015022770A8 (pt) 2019-11-26
KR20150126943A (ko) 2015-11-13
HUE043785T2 (hu) 2019-09-30
US20180258398A1 (en) 2018-09-13
DK2970912T3 (en) 2019-04-23
US20140273211A1 (en) 2014-09-18
CA2905786C (en) 2022-01-25
US20220228118A1 (en) 2022-07-21
US9938499B2 (en) 2018-04-10
HK1218927A1 (en) 2017-03-17

Similar Documents

Publication Publication Date Title
TR201904270T4 (tr) Tanımlı koşullar altında insan pluripotent kök hücrelerinin hematoendotelyal farklılaşması için yöntemler ve materyaller.
CY1121217T1 (el) Μεθοδοι για συγκομιδη καλλιεργειων κυτταρου θηλαστικων
IL249828A0 (en) Limbal stem cells of cultured mammals, methods of their creation and uses thereof
MX2020009670A (es) Metodos de cultivo por perfusion y usos de los mismos.
MX2015015406A (es) Matrices de micro-entornos de cultivos celulares discretos, metodos para producir estas matrices y usos de las mismas.
EP3436570A4 (en) MEDIUM, PROCEDURE, CELLS AND SECRETATED FACTORS FOR STEM CELL CULTURE AND THERAPY
GB2562396A (en) Devices for simulating a function of a liver tissue and methods of use and manufacturing thereof
UY35510A (es) ?composiciones y métodos para mejorar la estabilidad microbiana?.
EP3060650A4 (en) Culturing pluripotent stem cells
RS54073B1 (en) STROMAL MATERIAL CELLS
TW201612308A (en) Collector architecture layout design
UY34167A (es) Pirrolotriazinas sustituidas con hidroximetilarilo y sus usos
MX2015010943A (es) Metodos de cultivo por perfusión con microportadores y usos de los mismos.
MX2019009189A (es) Metodos de cultivo por perfusion con microportadores y usos de los mismos.
EP3124602A4 (en) Culture medium for pluripotent stem cells
MX2015011781A (es) Medio de cultivo celular y metodos de produccion de anticuerpos.
EP3184627A4 (en) Culture medium for mesenchymal stem cells
EP3006558A4 (en) METHOD OF STEM CELL CULTIVATION
IL243634A0 (en) Method and medium for in vitro growth of stem cells
DK3436568T3 (da) Kulturmedium til pluripotente stamceller
MX2022000516A (es) Metodos relacionados con celulas pluripotentes.
MY178060A (en) Methods of preparing a poloxamer for use in cell culture medium
EP3064576A4 (en) POLYPEPTIDE COMPOSITION AND CULTURING PROCESS FOR PLURIPOTENTE STEM CELLS THEREWITH
EA201690684A1 (ru) Способ осветления выросшей клеточной массы неочищенной культуры клеток с высокой плотностью клеток
EP3194573A4 (en) Mammalian pluripotent stem cells, methods for their production, and uses thereof